CytoSorbents Corp (CTSO)
0.8147
+0.01
(+1.58%)
USD |
NASDAQ |
Apr 22, 16:00
0.8147
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Enterprise Value: 35.14M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 35.14M |
| April 19, 2024 | 34.46M |
| April 18, 2024 | 34.40M |
| April 17, 2024 | 33.80M |
| April 16, 2024 | 34.22M |
| April 15, 2024 | 37.97M |
| April 12, 2024 | 38.26M |
| April 11, 2024 | 40.04M |
| April 10, 2024 | 43.03M |
| April 09, 2024 | 44.11M |
| April 08, 2024 | 43.16M |
| April 05, 2024 | 45.75M |
| April 04, 2024 | 42.76M |
| April 03, 2024 | 41.11M |
| April 02, 2024 | 42.76M |
| April 01, 2024 | 40.26M |
| March 28, 2024 | 42.49M |
| March 27, 2024 | 41.40M |
| March 26, 2024 | 39.23M |
| March 25, 2024 | 40.17M |
| March 22, 2024 | 39.23M |
| March 21, 2024 | 37.60M |
| March 20, 2024 | 38.08M |
| March 19, 2024 | 39.23M |
| March 18, 2024 | 43.36M |
| Date | Value |
|---|---|
| March 15, 2024 | 38.69M |
| March 14, 2024 | 43.57M |
| March 13, 2024 | 45.75M |
| March 12, 2024 | 45.21M |
| March 11, 2024 | 47.38M |
| March 08, 2024 | 47.38M |
| March 07, 2024 | 46.83M |
| March 06, 2024 | 44.12M |
| March 05, 2024 | 43.20M |
| March 04, 2024 | 42.49M |
| March 01, 2024 | 42.37M |
| February 29, 2024 | 42.93M |
| February 28, 2024 | 43.52M |
| February 27, 2024 | 42.98M |
| February 26, 2024 | 44.27M |
| February 23, 2024 | 44.07M |
| February 22, 2024 | 44.61M |
| February 21, 2024 | 45.15M |
| February 20, 2024 | 46.24M |
| February 16, 2024 | 45.69M |
| February 15, 2024 | 45.69M |
| February 14, 2024 | 45.69M |
| February 13, 2024 | 45.69M |
| February 12, 2024 | 45.15M |
| February 09, 2024 | 46.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
22.13M
Minimum
Sep 26 2022
424.77M
Maximum
Feb 04 2021
172.80M
Average
145.59M
Median
Oct 18 2019
Enterprise Value Benchmarks
| Delcath Systems Inc | 117.87M |
| Star Equity Holdings Inc | 11.65M |
| Exact Sciences Corp | 12.92B |
| Illumina Inc | 19.55B |
| Progyny Inc | 2.820B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.835M |
| Revenue (Quarterly) | 7.348M |
| Total Expenses (Quarterly) | 16.69M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 54.32% |
| Profit Margin (Quarterly) | -79.40% |
| Earnings Yield | -78.56% |
| Normalized Earnings Yield | -82.77 |